Viewing Study NCT00780104

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-02-01 @ 7:57 PM
Study NCT ID: NCT00780104
Status: COMPLETED
Last Update Posted: 2019-07-12
First Post: 2008-10-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sirolimus in Combination With MEC in High Risk Myeloid Leukemias
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Leukemias View
None AML View
None Leukemia View
None CML View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced myeloid leukemias View
None AML View
None Leukemia View
None Relapsed myeloid leukemias View
None Refractory myeloid leukemias View
None MEC View
None Rapamycin View
None Sirolimus View